Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer

OBJECTIVE: To evaluate the efficacy of bevacizumab a monoclonal, antivascular endothelial growth factor antibody in combination with cytotoxic chemotherapy in Turkish patients with recurrent and metastatic cervical cancer. MATERIALS AND METHODS: Data of 64 patients with metastatic or recurrent cervi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Turk J Obstet Gynecol
Autors principals: Ercelep, Özlem, Tataroğlu, Deniz, Özçelik, Melike, Sürmeli, Heves, Değirmenci, Mustafa, İnanç, Mevlüde, Aliustaoğlu, Mehmet, Gümüş, Mahmut
Format: Artigo
Idioma:Inglês
Publicat: Galenos Publishing 2020
Matèries:
Clinical Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7406906/
https://ncbi.nlm.nih.gov/pubmed/32850187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjod.galenos.2020.90699
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars